Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | TDO2 | P48775 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19435369 | 1.00 | AOC3 (0.44) | AOC3IDO1TDO2HTTHDAC3 | |
| SCHEMBL17894162 | 1.00 | AOC3 (0.44) | AOC3IDO1TDO2HTTHDAC3 | |
| SCHEMBL26430183 | 0.91 | ACHE (0.54) | AOC3ACHEALDH1A1DRD2DRD4 | |
| SCHEMBL26430202 | 0.91 | ACHE (0.54) | AOC3ACHEALDH1A1DRD2DRD4 | |
| SCHEMBL26321836 | 0.91 | ACHE (0.54) | AOC3ACHEALDH1A1DRD2DRD4 | |
| SCHEMBL30211236 | 0.88 | USP2 (0.41) | AOC3KDM4EALDH1A1 | |
| SCHEMBL15050864 | 0.80 | AOC3 (0.44) | AOC3IDO1TDO2HTTHDAC3 | |
| SCHEMBL15050397 | 0.80 | AOC3 (0.44) | AOC3IDO1TDO2HTTHDAC3 | |
| SCHEMBL15050395 | 0.80 | AOC3 (0.44) | AOC3IDO1TDO2HTTHDAC3 | |
| SCHEMBL17086688 | 0.80 | AOC3 (0.44) | AOC3IDO1TDO2HTTHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11639334-B2 | Methods for synthesis of oxypicolinamides | CORTEVA AGRISCIENCE LLC (US) | 2023-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639334-B2 | Methods for synthesis of oxypicolinamides | CYP51A1, CYP4X1, CYP4F3 | AOC3 132/4885IDO1 288/4885TDO2 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.